Skip to main content
Log in

Yohimbine premedication and 35% CO2 vulnerability in healthy volunteers

  • Original Paper
  • Published:
European Archives of Psychiatry and Clinical Neuroscience Aims and scope Submit manuscript

Summary

A group of 20 healthy volunteers underwent a 35% carbon dioxide / 65% oxygen air-placebo controlled challenge test twice, premedicated 1 h before with either 20 mg yohimbine or placebo, following a double-blind randomized crossover design. Contrary to expectation the anxiety response to carbon dioxide was not higher when premedicated with yohimbine compared to premedication with placebo. Possible implications of this finding are discussed, with reference to general chemical models of panic.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Albus M, Zahn T, Breier A (1992) Anxiogenic properties of yohimbine. I. Behavioral physiological and biochemical measures. Eur Arch Psychiatry Clin Neurosci 241:337–344

    Google Scholar 

  • American Psychiatric Association (1987) DSM-III-R. Diagnostic and statistical manual of mental disorders (DSM-III-R), 3rd edn., revised. American Psychiatric Association, Washington DC

    Google Scholar 

  • Bradwejn J, Koszycki D (1991) Comparison of the panicogenic effect of cholecystokinin 30–33 and carbon dioxide in panic disorder. Prog Neuropsychopharmacol Biol Psychiatry 15: 237–239

    Google Scholar 

  • Charney DS, Heninger GR, Redmond DE Jr (1983) Yohimbine induced anxiety and increased noradrenergic function in humans: effects of diazepam and clonidine. Life Sci 33:19–29

    Google Scholar 

  • Charney DS, Heninger GR, Breier A (1984) Noradrenergic function in panic anxiety. Arch Gen Psychiatry 41:751–763

    Google Scholar 

  • Charney DS, Woods SW, Goodman WK et al. (1987) Neurobiological mechanisms of panic anxiety: biochemical and behavioral correlates of yohimbine-induced panic attacks. Am J Psychiatry 144(8):1030–1036

    Google Scholar 

  • Clarck D (1986) A cognitive approach to panic. Beh Res Ther 24(4):461–470

    Google Scholar 

  • Elam M, Yao T, Thoren P et al (1981) Hypercapnia and hypoxia: chemoreceptor-mediated control of locus coeruleus neurons and splanchnic sympathetic nerves. Brain Research 222:373–381

    Google Scholar 

  • Fyer MR, Uy Jr, Goetz R et al. (1987) CO2 challenge of patients with panic disorder. Am J Psychiatry 24:1080–1082

    Google Scholar 

  • Gorman J, Askanazi J, Liebowitz M et al. (1984) Response to hyperventilation in a group of patients with panic disorder. Am J Psychiatry 141:857–861

    Google Scholar 

  • Gorman J, Fyer M, Liebowitz M et al. (1987) Pharmacologic provocation of panic attacks. In: Meltzer HY, Psychopharmacology: a third generation of progress. Raven Press, New York, pp 985–993

    Google Scholar 

  • Gorman J, Liebowitz M, Fyer A et al (1989) A neuroanatomical hypothesis for panic disorder. Am J Psychiatry 146:148–161

    Google Scholar 

  • Griez EJL, Lousberg H, van den Hout M et al. (1987) CO2 vulnerability in panic disorder. Psychiatry Res 20:87–95

    Google Scholar 

  • Griez EJL, de Loof C, Pols H et al. (1990) Specific sensitivity of patients with panic attacks to carbon dioxide inhalation. Psychiatry Res 31:193–199

    Google Scholar 

  • Griez EJL, Zandbergen J, Pols H et al. (1990) Response to 35% CO2 as a marker of panic in severe anxiety. Am J Psychiatry 145:796–797

    Google Scholar 

  • Guttmacher LB, Murphy DL, Insel TR (1983) Pharmacologic models of anxiety. Compr Psychiatry 24:312–326

    Google Scholar 

  • Hoehn-Saric R, Merchant A, Keyser M et al (1981) Effects of clonidine on anxiety disorder. Arch Gen Psychiatry 38:1278–1282.

    Google Scholar 

  • Liebowitz M, Fyer A, McGrath P et al (1981) Clonidine treatment of panic disorder. Psychopharm Bull 17:122–123

    Google Scholar 

  • Mason S, Fibiger H (1979) Current concepts in anxiety: the locus coeruleus disconnection. Life Sci 25:2141–2147

    Google Scholar 

  • Mattila M, Seppala T, Mattila MJ (1988) Anxiogenic effects of yohimbine in healthy subjects: comparison with caffeine and antagonism by clonidine and diazepam. Int Clin Psychopharmacol 3:215–229

    Google Scholar 

  • Papp LA, Klein DF, Martinez J et al. (1993) Diagnostic and substance specificity of carbon dioxide-induced panic. Am J Psychiatry 150:250–257

    Google Scholar 

  • Pols H, Zandbergen J, de Loof C et al. (1991) Attenuation of carbon dioxide-induced panic after clonazepam treatment. Acta Psychiatr Scand 84:885–886

    Google Scholar 

  • Pols H, Griez EJL, Zandbergen J (1989) Does buspirone have anxiogenic properties. Lancet II:682–683

    Google Scholar 

  • Redmond D Jr (1977) Alterations in the function of the nucleus locus coeruleus: a possible model for studies of anxiety. In: Hanin, Usdin (eds) Animal models in psychiatry and neurology. Pergamon Press, Oxford

    Google Scholar 

  • Spielberger CD, Gorsuch R, Lushene RN (1970) Manual for the state-trait anxiety inventory. Consulting Psychologists Press, Palo Alto, Calif.

    Google Scholar 

  • Uhde TW, Tancer ME (1990) Chemical models of panic: a review and critique. In: Tyrer P (ed) Psychopharmacology of anxiety. University Press, London, Oxford, pp 109–131

    Google Scholar 

  • Van den Hout M, Griez E (1984) Panic symptoms after inhalation of carbon dioxide. Brit J Psychiatry 144:503–507

    Google Scholar 

  • Woods SW, Charney DS, Loke J et al. (1986) Carbon dioxide sensitivity in panic anxiety: ventilatory and anxiogenic responses to carbon dioxide in healthy subjects and patients with panic anxiety before and after alprazolam treatment. Arch Gen Psychiatry 43:900–909

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pols, H., Griez, E., Verburg, K. et al. Yohimbine premedication and 35% CO2 vulnerability in healthy volunteers. Eur Arch Psychiatry Clin Nuerosci 244, 81–85 (1994). https://doi.org/10.1007/BF02193523

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02193523

Key words

Navigation